| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / ORAL | | 7 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION/ DROPS / AURICULAR (OTIC) | | 1 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / PERIODONTAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM, EXTENDED RELEASE / TRANSDERMAL | 0.85 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | | 3315 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAMUSCULAR | | 101 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / SUBCUTANEOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | | 16734 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / RESPIRATORY (INHALATION) | | 5 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRAVENOUS | | 78 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / SUBCUTANEOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CONCENTRATE / ORAL | | 7000 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION/ DROPS / TOPICAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CREAM / TOPICAL | | 1 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / NASAL | | 5 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LOTION, AUGMENTED / TOPICAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION, CONCENTRATE / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYRUP / ORAL | | 5700 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | | 450 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRA-ARTERIAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / RECTAL | | 90400 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | DROPS / OPHTHALMIC | NA | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAMUSCULAR | | 7459 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / OPHTHALMIC | | 6 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | GRANULE, FOR SUSPENSION / ORAL | | 30 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / OPHTHALMIC | 0.05 %w/v | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | | 27 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SUBCONJUNCTIVAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SPRAY, METERED / NASAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAMUSCULAR | | 4000 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRASYNOVIAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRATHECAL | 176 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY, METERED / NASAL | 1.2 mg/1ml | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM, SOLUBLE / ORAL | | 11 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CONCENTRATE / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / IONTOPHORESIS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | | 3822 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRACAUDAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | | 34 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAOCULAR | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CONCENTRATE / ORAL | 10 mg/5ml | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVENOUS | | 456 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / RESPIRATORY (INHALATION) | | 1 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | | 230 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET, FILM COATED / ORAL | | 8 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTERSTITIAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / NASAL | | 5 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAMUSCULAR | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | OINTMENT, AUGMENTED / TOPICAL | 0.11 %w/w | | Exact identifier — unii candidate 174 equally ranked IID candidates |